proton therapy

Steven Frank: Phase III Level I evidence for proton therapy in head and neck malignancies to be presented at ASCO

Steven Frank, Executive Director of Particle Therapy Institute at MD Anderson Cancer Center, shared on X:

“Congratulations to all participating institutions for driving Phase III Level I evidence for proton therapy in head and neck malignancies to be presented at ASCO on June 4th.”         .

View additional information.
Source: Steven Frank/X

ASCO24 cancer head and neck malignancies OncoDaily Oncology proton therapy Steven Frank The University of Texas MD Anderson Cancer Center